Literature DB >> 3031579

Pertussis toxin inhibits negative inotropic and negative chronotropic muscarinic cholinergic effects on the heart.

S Tucek, V Dolezal, J Folbergrová, S Hynie, F Kolár, B Ostádal.   

Abstract

We injected rats with pertussis toxin, known to cause ADP ribosylation of the Gi regulatory protein of the adenylate cyclase complex and of another closely related GTP binding protein in the heart, and after 7 days we examined several effects of muscarinic activation on the heart. The negative chronotropic effect of carbamoylcholine on spontaneously beating perfused hearts was conspicuously diminished. While 10(-5) mol/l carbamoylcholine invariably produced heart arrest in control rats, the heart rate did not decrease by more than 20% in the toxin-treated rats even when the concentration of carbamoylcholine was raised to 10(-2) mol/l. The negative inotropic effect of carbamoylcholine examined on electrically paced ventricles perfused with isoproterenol was reduced, while the maximum positive inotropic effect of isoproterenol was substantially increased after toxin treatment. The inhibitory action of carbamoylcholine on the isoproterenol-stimulated accumulation of cyclic AMP in the heart auricles was attenuated. The weakening by pertussis toxin of the negative inotropic effect of carbamoylcholine is probably mainly due to the ADP ribosylation of the Gi regulatory protein and the subsequent loss of influence of muscarinic receptors on adenylate cyclase. The blockade of the negative chronotropic action of carbamoylcholine by pertussis toxin strongly indicates, together with other recently published evidence, that the Gi or another closely related GTP binding protein in the cardiac pacemaker cells is involved in the coupling of muscarinic receptors to the K+ channels.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3031579     DOI: 10.1007/BF00581347

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  28 in total

Review 1.  The parasympathetic neuroeffector junction of the heart.

Authors:  K Löffelholz; A J Pappano
Journal:  Pharmacol Rev       Date:  1985-03       Impact factor: 25.468

2.  Injection of subunits of cyclic AMP-dependent protein kinase into cardiac myocytes modulates Ca2+ current.

Authors:  W Osterrieder; G Brum; J Hescheler; W Trautwein; V Flockerzi; F Hofmann
Journal:  Nature       Date:  1982-08-05       Impact factor: 49.962

3.  Ontogenesis of physiological responsiveness and guanine nucleotide sensitivity of cardiac muscarinic receptors during chick embryonic development.

Authors:  S W Halvorsen; N M Nathanson
Journal:  Biochemistry       Date:  1984-11-20       Impact factor: 3.162

4.  Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain.

Authors:  P C Sternweis; J D Robishaw
Journal:  J Biol Chem       Date:  1984-11-25       Impact factor: 5.157

5.  Mechanisms of muscarinic modulation of protein phosphorylation in intact ventricles.

Authors:  A M Watanabe; J P Lindemann; J W Fleming
Journal:  Fed Proc       Date:  1984-08

6.  Modification by islet-activating protein of receptor-mediated regulation of cyclic AMP accumulation in isolated rat heart cells.

Authors:  O Hazeki; M Ui
Journal:  J Biol Chem       Date:  1981-03-25       Impact factor: 5.157

7.  Muscarinic antagonism of the effects of phosphodiesterase inhibitor (methylisobutylxanthine) in embryonic chick ventricle.

Authors:  R L Biegon; P M Epstein; A J Pappano
Journal:  J Pharmacol Exp Ther       Date:  1980-11       Impact factor: 4.030

8.  Pertussis toxin treatment blocks hyperpolarization by muscarinic agonists in chick atrium.

Authors:  S Sorota; Y Tsuji; T Tajima; A J Pappano
Journal:  Circ Res       Date:  1985-11       Impact factor: 17.367

9.  Uncoupling of cardiac muscarinic and beta-adrenergic receptors from ion channels by a guanine nucleotide analogue.

Authors:  G E Breitwieser; G Szabo
Journal:  Nature       Date:  1985 Oct 10-16       Impact factor: 49.962

10.  Islet activating protein inhibits physiological responses evoked by cardiac muscarinic acetylcholine receptors. Role of guanosine triphosphate binding proteins in regulation of potassium permeability.

Authors:  J M Martin; D D Hunter; N M Nathanson
Journal:  Biochemistry       Date:  1985-12-17       Impact factor: 3.162

View more
  6 in total

1.  Failure of the calcium channel activator, Bay K 8644, to increase the release of acetylcholine from nerve terminals in brain and diaphragm.

Authors:  V Dolezal; S Tucek
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

2.  Physiological antagonism between ventricular beta 1-adrenoceptors and alpha 1-adrenoceptors but no evidence for beta 2- and beta 3-adrenoceptor function in murine heart.

Authors:  Jürgen F Heubach; Thomas Rau; Thomas Eschenhagen; Ursula Ravens; Alberto J Kaumann
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

3.  Pertussis toxin-sensitive G proteins influence nitric oxide synthase III activity and protein levels in rat heart.

Authors:  J M Hare; B Kim; N A Flavahan; K M Ricker; X Peng; L Colman; R G Weiss; D A Kass
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

4.  Pertussis toxin prevents adenosine receptor- and m-cholinoceptor-mediated sinus rate slowing and AV conduction block in the guinea-pig heart.

Authors:  M Böhm; W Schmitz; H Scholz; A Wilken
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

5.  Evidence against a role of nitric oxide in the indirect negative inotropic-effect of M-cholinoceptor stimulation in human ventricular myocardium.

Authors:  H Kilter; O Lenz; K La Rosée; M Flesch; R H Schwinger; M Mädge; F Kuhn-Regnier; M Böhm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-09       Impact factor: 3.000

6.  Pertussis Toxin Promotes Pulmonary Hypertension in an Infant Mouse Model of Bordetella pertussis Infection.

Authors:  Karen M Scanlon; Ling Chen; Nicholas H Carbonetti
Journal:  J Infect Dis       Date:  2022-01-05       Impact factor: 7.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.